Results 361 to 370 of about 9,044,537 (408)
Some of the next articles are maybe not open access.

Antineoplastic Drug Monitoring

Clinics in Laboratory Medicine, 1987
The ability to monitor biologically significant levels of antineoplastic drugs in patients' plasma is rapidly expanding. The expanded application of therapeutic drug monitoring to the clinical practice of oncology will require a better understanding of the relationship between drug levels, toxicity, and therapeutic benefit in particular patient ...
openaire   +2 more sources

Therapeutic Drug Monitoring of Long-Acting Injectable Antipsychotic Drugs.

Therapeutic Drug Monitoring, 2020
PURPOSE The use of therapeutic drug monitoring (TDM) to guide treatment with long-acting injectable (LAI) antipsychotics, which are increasingly prescribed, remains a matter of debate.
G. Schoretsanitis   +15 more
semanticscholar   +1 more source

Therapeutic drug monitoring with biologic agents in immune mediated inflammatory diseases

Expert Review of Clinical Immunology, 2019
Introduction: Biologic therapy has revolutionized the treatment of immune mediated inflammatory diseases (IMID), such as inflammatory bowel disease (IBD), rheumatoid and psoriatic arthritis, ankylosing spondylitis and psoriasis.
K. Papamichael   +4 more
semanticscholar   +1 more source

Drug level monitoring of antiasthmatic drugs

Journal of Chromatography B: Biomedical Sciences and Applications, 1985
In general assays pertaining to drug level monitoring (DLM) of antiasthmatic agents (except theophylline), published during the period 1978-1983, used mostly high-performance liquid chromatographic (HPLC) methodology (approximately 45%) with mass spectrometric (MS) based assays in second place (approximately 30%) followed by immunochemical techniques ...
N, Kucharczyk, F H, Segelman
openaire   +2 more sources

Therapeutic Drug Monitoring of Antiarrhythmic Drugs

Clinical Pharmacokinetics, 2003
Most antiarrhythmic drugs fulfil the formal requirements for rational use of therapeutic drug monitoring, as they show highly variable plasma concentration profiles at a given dose and a direct concentration-effect relationship. Therapeutic ranges for antiarrhythmic drugs are, however, often very poorly defined.
Gesche, Jürgens   +2 more
openaire   +2 more sources

Therapeutic drug monitoring

Clinical Pharmacology and Therapeutics, 1988
R, Spector   +3 more
openaire   +4 more sources

Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies

Ca-A Cancer Journal for Clinicians, 2022
Paolo Tarantino   +2 more
exaly  

Therapeutic drug monitoring

2014
Amitava Dasgupta, Amer Wahed
openaire   +1 more source

Cancer epigenetics in clinical practice

Ca-A Cancer Journal for Clinicians, 2023
Veronica Davalos, Manel Esteller
exaly  

Home - About - Disclaimer - Privacy